EX-4.2



 Exhibit 4.2 

VOTING AGREEMENT 

THIS VOTING AGREEMENT, dated as of [●], 2016, is entered into by and between (i) Dr. August J. Troendle (“Dr.
Troendle”) and (ii) the entities listed on Schedule 1 attached hereto (collectively, the “Cinven Stockholders” and, together with Dr. Troendle, the “Principal Stockholders”).
Capitalized terms used herein without definition shall have the meanings set forth in Section 1.1. 
 W I T
N E S S E T H: 
 WHEREAS, the parties hereto desire to set forth their agreement with
respect to the voting for members of the Board of Directors of Medpace Holdings, Inc., a corporation organized under the laws of Delaware (the “Company”), in connection with their respective investments in the Company; 

NOW, THEREFORE, in consideration of the mutual agreements and understandings set forth herein, the parties hereto hereby agree as follows:

 ARTICLE I 
 CERTAIN
DEFINITIONS 
 SECTION 1.1 Definitions As used in this Agreement, the following terms shall have the following respective
meanings: 
 “Agreement” shall mean this Voting Agreement as in effect on the date hereof and as hereafter from time to
time amended, modified or supplemented in accordance with the terms hereof. 
 “Board of Directors” shall mean the Board of
Directors of the Company. 
 “Bylaws” shall mean the Bylaws of the Company, as they may be amended, modified or
supplemented in accordance with their terms. 
 “Common Shares” shall mean the shares of common stock, par value $0.01 per
share, of the Company. 
 “Director” shall mean a member of the Board of Directors. 

“Effective Date” shall have the meaning set forth in Section 4.11. 

“Initial Public Offering” means the first public offering and sale of equity securities of the Company pursuant to an
effective registration statement under the Securities Act of 1933, as amended. 
 “Cinven Directors” shall mean the persons
affiliated with the Cinven Stockholders who are nominated for election as a Director. The initial Cinven Directors shall be Supraj Rajagopalan, Alex Leslie and Matthew Norton. 







 “Management Director” shall mean Dr. August J. Troendle. 

“Person” shall mean an individual, corporation, company, limited liability company, association, partnership, joint venture,
organization, business, trust or any other entity or organization, including a government or any subdivision or agency thereof. 

“Shares” shall mean (i) the Common Shares issued and outstanding at the Effective Date and held by any Principal
Stockholder and (ii) any Common Shares hereafter acquired by any Principal Stockholder, including pursuant to conversion or exercise of any option, convertible security or warrant or other right to acquire Common Shares, whether or not held by
any of the Principal Stockholders as of the Effective Date. 
 “Voting Shares” shall mean shares of capital stock of the
Company of any class, classes or series, the holders of which are generally entitled to vote for the election of Directors. 
 ARTICLE II

 AGREEMENT TO VOTE SHARES 

SECTION 2.1 Board of Directors. Each Principal Stockholder hereby agrees to vote all Shares owned or held of record by such
Principal Stockholder at each annual or special meeting of stockholders of the Company (and at every adjournment or postponement thereof) at which Directors are to be elected, in favor of, or to take all actions by written consent in lieu of any
such meeting as are necessary to cause, the election as members of the Board of Directors of (in each case, to the extent such persons are recommended to the Board of Directors for nomination for election as a Director by the Nominating and
Corporate Governance Committee of the Board of Directors (or in the event the Nominating and Corporate Governance Committee of the Board of Directors is not yet formed or has no sitting members, to the extent such persons are recommended by the
Board of Directors for nomination for election as a Director)): 
 (i) the Cinven Directors; and 

(ii) so long as at the time of such vote, Dr. Troendle is the Chief Executive Officer of the Company (as defined in the Bylaws), the
Management Director. 
 Notwithstanding the obligations set forth in Section 2.1(i) above, in the event that the Cinven Stockholders hold less than
(a) 40% but greater than or equal to 25% of the Voting Shares of the Company then outstanding, Dr. Troendle shall be required to vote for two Cinven Directors, after giving effect to the Cinven Directors then-sitting on the Board of
Directors, (b) 25% but greater than or equal to 10% of the Voting Shares of the Company then outstanding, Dr. Troendle shall be required to vote for one Cinven Director, after giving effect to the Cinven Directors then-sitting on the Board
of Directors, and (c) 10% of the Voting Shares of the Company then outstanding, Dr. Troendle shall not be required to vote for any of the Cinven Directors pursuant to this Section 2.1. 

SECTION 2.2 Restrictions on Other Agreements. No Principal Stockholder shall grant any proxy or enter into or agree to be bound by
any voting trust, agreement or arrangement of any kind with any Person with respect to its Shares if and to the extent the terms thereof conflict 

  
 2 








 
with the provisions of this Agreement (whether or not such proxy, voting trust, agreements or arrangements are with other Principal Stockholders, holders of Common Shares that are not parties to
this Agreement or otherwise). 
 ARTICLE III 

REPRESENTATIONS AND WARRANTIES 

Each of the parties to this Agreement hereby represents and warrants to each other party to this Agreement that as of the date such party
executes this Agreement: 
 SECTION 3.1 Existence; Authority; Enforceability. Such party has the power and authority to enter
into this Agreement and to carry out its obligations hereunder. If such party is an entity, it is duly organized and validly existing under the laws of its jurisdiction of organization, and the execution of this Agreement, and the consummation of
the transactions contemplated herein, have been authorized by all necessary action, and no other act or proceeding on its part is necessary to authorize the execution of this Agreement or the consummation of any of the transactions contemplated
hereby. If such party is a natural person, such person has full capacity to contract. This Agreement has been duly executed by each of the parties hereto and constitutes his or its legal, valid and binding obligation, enforceable against him or it
in accordance with its terms, except as enforcement may be limited by applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent transfer and similar laws relating to or affecting creditors’ rights generally, or by the general
principles of equity. No representation is made by any party with respect to the regulatory effect of this Agreement, and each of the parties has had an opportunity to consult with counsel as to his or its rights and responsibilities under this
Agreement. No party makes any representation to any other party as to future law or regulation or the future interpretation of existing laws or regulations by any governmental authority or self-regulatory organization. 

SECTION 3.2 Absence of Conflicts. The execution and delivery by such party of this Agreement and the performance of its
obligations hereunder does not and will not (i) conflict with, or result in the breach of, any provision of the constitutive documents of such party, if any; (ii) result in any violation, breach, conflict, default or event of default (or
an event which with notice, lapse of time, or both, would constitute a default or event of default), or give rise to any right of acceleration or termination or any additional payment obligation, under the terms of any contract, agreement or permit
to which such party is a party or by which such party’s assets or operations are bound or affected; or (iii) violate any law applicable to such party. 

SECTION 3.3 Consents. Other than any consents which have already been obtained, no consent, waiver, approval, authorization,
exemption, registration, license or declaration is required to be made or obtained by such party in connection with the execution, delivery or performance of this Agreement. 

  
 3 








 ARTICLE IV 

MISCELLANEOUS 
 SECTION
4.1 Termination. This Agreement shall terminate and be of no further force and effect upon the earliest to occur of: (a) Dr. Troendle and the Cinven Stockholders ceasing to collectively own at least 40% of the Voting Shares of
the Company then outstanding, (b) the written agreement of Dr. Troendle, on the one hand, and the Cinven Stockholders, on the other hand, to terminate this Agreement, (c) the provisions of Article II hereof becoming illegal or being
interpreted by any governmental authority to be illegal, (d) the removal of Dr. Troendle as the Chief Executive Officer of the Company solely by the action of the Board of Directors, or (e) any exchange on which the Company’s
Common Shares are traded asserting, in writing, that the existence of this Agreement will threaten the continued listing of the Company’s Common Shares on such exchange. 

SECTION 4.2 Successors and Assigns; Beneficiaries. Except as otherwise provided herein, all of the terms and provisions of this
Agreement shall be binding upon, shall inure to the benefit of and shall be enforceable by the respective successors and permitted assigns of the parties hereto. 

SECTION 4.3 Amendment and Modification; Waiver of Compliance (a) This Agreement may be amended only by a written instrument duly
executed by Dr. Troendle and the Cinven Stockholders. 
 (b) Except as otherwise provided in this Agreement, any failure of any of the
parties hereto to comply with any obligation, covenant, agreement or condition herein may be waived by the party entitled to the benefits thereof only by a written instrument signed by the party granting such waiver, but such waiver or failure to
insist upon strict compliance with such obligation, covenant, agreement or condition shall not operate as a waiver of, or estoppel with respect to, any subsequent or other failure. 

SECTION 4.4 Notices. Any notice, request, claim, demand, document and other communication hereunder to any party shall be
effective upon receipt (or refusal of receipt) and shall be in writing and delivered personally or sent by facsimile, or first class mail, or by Federal Express, United Parcel Service or other similar courier or other similar means of communication,
as follows: 
 (i) If to Dr. Troendle, addressed to: 

Medpace Holdings, Inc. 
 5375
Medpace Way 
 Cincinnati, Ohio 45227 

Attn: Dr. August Troendle 

Facsimile: (513) 579-0444 

(ii) If to (a) Fifth Cinven Fund (No.1) Limited Partnership, (b) Fifth Cinven Fund (No.2) Limited Partnership,
(c) Fifth Cinven Fund (No.3) Limited Partnership, 

  
 4 








 
(d) Fifth Cinven Fund (No.4) Limited Partnership, (e) Fifth Cinven Fund (No.5) Limited Partnership or (f) Fifth Cinven Fund (No.6) Limited Partnership, addressed to: 

East Wing 
 Trafalgar Court

 Les Banques 
 St Peter Port

 Guernsey 
 GY1 3PP 

(iii) If to Fifth Cinven Fund Co-Investment Partnership, addressed to: 

Warwick Court 
 Paternoster
Square 
 London 
 United
Kingdom 
 EC4M 7AG 

(iv) If to Fifth Cinven Fund FCP-SIF, addressed to: 

7, rue Lou Hemmer 
 L-1748 

Luxembourg 
 or, in each case, to such other
address or facsimile number or email address as such party may designate in writing to each Principal Stockholder by written notice given in the manner specified herein. 

All such communications shall be deemed to have been given, delivered or made when so delivered by hand or sent by facsimile (with confirmed
transmission), on the next business day if sent by overnight courier service (with confirmed delivery) or when received if sent by first class mail. 

SECTION 4.5 Entire Agreement. The provisions of this Agreement and the other writings referred to herein or delivered pursuant
hereto which form a part hereof contain the entire agreement among the parties hereto with respect to the subject matter hereof and supersede all prior oral and written agreements and memoranda and undertakings among the parties hereto with regard
to such subject matter. 
 SECTION 4.6 CHOICE OF LAW AND VENUE; WAIVER OF RIGHT TO JURY TRIAL. THIS AGREEMENT SHALL BE GOVERNED
BY, CONSTRUED, APPLIED AND ENFORCED IN ACCORDANCE WITH THE INTERNAL LAWS OF THE STATE OF DELAWARE, WITHOUT GIVING EFFECT TO PRINCIPLES OF CONFLICTS OF LAW. EACH OF THE PARTIES HERETO ACKNOWLEDGES AND AGREES THAT IN THE EVENT OF ANY BREACH OF THIS
AGREEMENT, THE NON-BREACHING PARTY WOULD BE IRREPARABLY HARMED AND COULD NOT BE MADE WHOLE BY MONETARY DAMAGES, AND THAT, IN ADDITION TO ANY OTHER REMEDY TO WHICH THE NON-BREACHING PARTY MAY BE ENTITLED AT LAW OR IN EQUITY,


  
 5 








 
THE NON BREACHING PARTY SHALL BE ENTITLED TO SUCH EQUITABLE OR INJUNCTIVE RELIEF AS MAY BE APPROPRIATE. THE CHOICE OF FORUM SET FORTH IN THIS SECTION SHALL NOT BE DEEMED TO PRECLUDE THE
ENFORCEMENT OF ANY JUDGMENT OF A DELAWARE FEDERAL OR STATE COURT, OR THE TAKING OF ANY ACTION UNDER THIS AGREEMENT TO ENFORCE SUCH A JUDGMENT, IN ANY OTHER APPROPRIATE JURISDICTION. 

IN THE EVENT ANY PARTY TO THIS AGREEMENT COMMENCES ANY LITIGATION, PROCEEDING OR OTHER LEGAL ACTION IN CONNECTION WITH OR RELATING TO THIS
AGREEMENT, ANY RELATED AGREEMENT OR ANY MATTERS DESCRIBED OR CONTEMPLATED HEREIN OR THEREIN, THE PARTIES TO THIS AGREEMENT HEREBY (A) AGREE UNDER ALL CIRCUMSTANCES ABSOLUTELY AND IRREVOCABLY TO INSTITUTE ANY LITIGATION, PROCEEDING OR OTHER
LEGAL ACTION IN A COURT OF COMPETENT JURISDICTION LOCATED WITHIN THE STATE OF DELAWARE, WHETHER A STATE OR FEDERAL COURT; (B) AGREE THAT IN THE EVENT OF ANY SUCH LITIGATION, PROCEEDING OR ACTION, SUCH PARTIES WILL CONSENT AND SUBMIT TO THE
PERSONAL JURISDICTION OF ANY SUCH COURT DESCRIBED IN CLAUSE (A) OF THIS SECTION AND TO SERVICE OF PROCESS UPON THEM IN ACCORDANCE WITH THE RULES AND STATUTES GOVERNING SERVICE OF PROCESS (IT BEING UNDERSTOOD THAT NOTHING IN THIS SECTION SHALL
BE DEEMED TO PREVENT ANY PARTY FROM SEEKING TO REMOVE ANY ACTION TO A FEDERAL COURT IN THE STATE OF DELAWARE); (C) AGREE TO WAIVE TO THE FULL EXTENT PERMITTED BY LAW ANY OBJECTION THAT THEY MAY NOW OR HEREAFTER HAVE TO THE VENUE OF ANY SUCH
LITIGATION, PROCEEDING OR ACTION IN ANY SUCH COURT OR THAT ANY SUCH LITIGATION, PROCEEDING OR ACTION WAS BROUGHT IN AN INCONVENIENT FORUM; (D) AGREE, AFTER CONSULTATION WITH COUNSEL, TO WAIVE ANY RIGHTS TO A JURY TRIAL TO RESOLVE ANY DISPUTES
OR CLAIMS RELATING TO THIS AGREEMENT; (E) AGREE TO SERVICE OF PROCESS IN ANY LEGAL PROCEEDING BY MAILING OF COPIES THEREOF TO SUCH PARTY AT ITS ADDRESS SET FORTH HEREIN FOR COMMUNICATIONS TO SUCH PARTY; (F) AGREE THAT ANY SERVICE MADE AS
PROVIDED HEREIN SHALL BE EFFECTIVE AND BINDING SERVICE IN EVERY RESPECT; AND (G) AGREE THAT NOTHING HEREIN SHALL AFFECT THE RIGHTS OF ANY PARTY TO EFFECT SERVICE OF PROCESS IN ANY OTHER MANNER PERMITTED BY APPLICABLE LAW. 

SECTION 4.7 Counterparts. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original,
but all of which together shall constitute one and the same instrument. 
 SECTION 4.8 Further Assurances. At any time or from
time to time after the date hereof, the parties hereto agree to cooperate with each other, and at the request of any other party, to execute and deliver any further instruments or documents and to take all such further action as any other party may
reasonably request in order to evidence or effectuate the provisions of this Agreement and to otherwise carry out the intent of the parties hereunder. 

  
 6 








 SECTION 4.9 Schedule 13D. In accordance with the requirements of Rule 13d-1(k) under
the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and subject to the limitations set forth therein, each party hereto agrees to file an appropriate Schedule 13D no later than 10 calendar days following the
Effective Date. 
 SECTION 4.10 Specific Performance. The parties hereto agree that the other parties would be irreparably
damaged in the event that any of the provisions of this Agreement were not performed by any of the parties in accordance with their specific terms or were otherwise breached by any party, and that the other parties would not have an adequate remedy
at law for money damages in such event. It is accordingly agreed that each of the parties shall be entitled, without posting any bond or other undertaking, to specific performance and injunctive and other equitable relief to prevent breaches of this
Agreement and to enforce specifically the terms and provisions of this Agreement, this being in addition to any other remedy to which each party is entitled at law or in equity. 

SECTION 4.11 Effectiveness of Agreement. Upon the closing of the Initial Public Offering, this Agreement shall thereupon be deemed
to be effective (such date, the “Effective Date”). However, to the extent the closing of such Initial Public Offering does not occur, the provisions of this Agreement shall be without any force or effect. 

*        *        * 

  
 7 








 IN WITNESS WHEREOF, each of the undersigned has signed this Agreement as of the date first above
written: 
  

			
	By:	 	  

	Name:	 	August J. Troendle



  
 Signature Page to
Voting Support Agreement 








 
			
	FIFTH CINVEN FUND (NO. 1) LIMITED PARTNERSHIP
	
	By: Cinven Capital Management (V) Limited Partnership Incorporated
	Its: General Partner
	
	By: Cinven Capital Management (V) General Partnership Incorporated
	Its: General Partner
		
	By:	 	  

	Name:	 	
	Title:	 	
	
	FIFTH CINVEN FUND (NO. 2) LIMITED PARTNERSHIP
	
	By: Cinven Capital Management (V) Limited Partnership Incorporated
	Its: General Partner
	
	By: Cinven Capital Management (V) General Partnership Incorporated
	Its: General Partner
		
	By:	 	  

	Name:	 	
	Title:	 	



  
 Signature Page to
Voting Support Agreement 









			
	FIFTH CINVEN FUND (NO. 3) LIMITED PARTNERSHIP
	
	By: Cinven Capital Management (V) Limited Partnership Incorporated
	Its: General Partner
	
	By: Cinven Capital Management (V) General Partnership Incorporated
	Its: General Partner
		
	By:	 	  

	Name:	 	
	Title:	 	
	
	FIFTH CINVEN FUND (NO. 4) LIMITED PARTNERSHIP
	
	By: Cinven Capital Management (V) Limited Partnership Incorporated
	Its: General Partner
	
	By: Cinven Capital Management (V) General Partnership Incorporated
	Its: General Partner
		
	By:	 	  

	Name:	 	
	Title:	 	



  
 Signature Page to
Voting Support Agreement 









			
	FIFTH CINVEN FUND (NO. 5) LIMITED PARTNERSHIP
	
	By: Cinven Capital Management (V) Limited Partnership Incorporated
	Its: General Partner
	
	By: Cinven Capital Management (V) General Partnership Incorporated
	Its: General Partner
		
	By:	 	  

	Name:	 	
	Title:	 	
	
	FIFTH CINVEN FUND (NO. 6) LIMITED PARTNERSHIP
	
	By: Cinven Capital Management (V) Limited Partnership Incorporated
	Its: General Partner
	
	By: Cinven Capital Management (V) General Partnership Incorporated
	Its: General Partner
		
	By:	 	  

	Name:	 	
	Title:	 	
	
	FIFTH CINVEN FUND CO-INVESTMENT PARTNERSHIP
	
	By: CIP (V) Nominees Limited
	Its: Partner
		
	By:	 	  

	Name:	 	
	Title:	 	



  
 Signature Page to
Voting Support Agreement 









			
	FIFTH CINVEN FUND FCP-SIF
	
	By: Cinven Manco S.A.R.L.
	Its: Manager
		
	By:	 	  

	Name:	 	
	Title:	 	



  
 Signature Page to
Voting Support Agreement 








 SCHEDULE 1 

CINVEN STOCKHOLDERS 
 Fifth Cinven Fund (No. 1)
Limited Partnership 
 Fifth Cinven Fund (No. 2) Limited Partnership 

Fifth Cinven Fund (No. 3) Limited Partnership 
 Fifth Cinven
Fund (No. 4) Limited Partnership 
 Fifth Cinven Fund (No. 5) Limited Partnership 

Fifth Cinven Fund (No. 6) Limited Partnership 
 Fifth Cinven
Fund Co-Investment Partnership 
 Fifth Cinven Fund FCP-SIF